AXL and adrenal cortex carcinoma: Molecular changes in genes that encode for epigenetic modifiers (SMARCA2, CREBBP, KDM6A), proliferation regulators (EGFR, PIK3CA, KRAS, AXL, MET, MYC) and tumor suppressors (ATM, CDKN2A, TP53) have also been noted in ACC patients [11, 18, 21].